Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dopamine/atrophy

Veza se sprema u međuspremnik
Stranica 1 iz 89 rezultatima

Dopaminergic Dysfunction in Late-Life Depression

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Late Life Depression (LLD) is a prevalent, disabling, and at times lethal condition for which currently available treatments are often ineffective. No prior study has comprehensively examined dopamine-dependent behaviors (i.e., reward processing, cognition, motor function) in LLD, and none has

Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The increasing prevalence of dementia is a serious threat to our medical system and our society. About 500,000 Canadians are affected with dementia, and this number will rise to more than 1 million in the next 20 years. Dementia already costs our economy 15 billion dollars per year. While much of

Dopaminergic restauratIon by intraVEntriculaire Administration

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Parkinson's disease (PD) is the second most frequent neurodegenerative disorder worldwide. The loss of dopamine through denervation in the striatum as a result of progressive neuronal degeneration in the substantia nigra pars compacta (SNpc), is the primary neurotransmitter marker of the disease.

Insulin Resistance in Multiple System Atrophy

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Multiple system atrophy (MSA) patients have a poor prognosis with a median survival ranging between 6 and 10 years. MSA belongs to the synucleinopathies, which are characterized by the abnormal accumulation of alpha-synuclein. We have recently shown brain insulin resistance (i.e. reduced insulin

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Natural History and Disease Progression Biomarkers of Multiple System Atrophy

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Surrogate biomarkers are objectively measured characteristics of a disease which act as indicators of the underlying pathophysiological processes responsible for disease progression. Reduced grey matter volume in putamen, cerebellum and brainstem as measured with MRI have been consistently reported

Molecular and Functional Imaging in SNCA, Parkin and PINK1

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
A short description, 5000 characters Intro: In phenotypic animal models of Parkinson's Disease (PD), chronic physical exercise has produced nigrostriatal neuroprotection and symptom improvement, provided training was of high-intensity and prolonged duration (>3 months in rodent models). Conventional

Physical Therapy and Cognitive Decline

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Non-pharmacological intervention may represent adjunctive therapy to medications in order to delay the onset of the cognitive deficits or dementia. Previous studies observed a positive effect of cognitive training on cognition both in healthy elderly people and patients in the early stage of

Search for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior Disorder

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
REM sleep behavior disorder (RBD) is a parasomnia characterized by dream enactment behaviors and REM sleep without muscle atonia (excessive EMG activity) during REM sleep.Increasing studies revealed that iRBD eventually converts to α-synucleinopathy, such as Parkinson's disease (PD), dementia with

Ultrasound Meal Accommodation Test for Enteral Feeding in the Critically Ill

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Within the context of intensive care units (ICU), enteral nutrition is an essential tool in the management of critical patients, because it preserves the structure and function of the gastrointestinal mucosa, decreases the catabolic response to injury when it is administered early, and could also

Unravelling the Alteration of Brain Structure and Function in Parkinson´s Disease With Ultra-high Field MRI

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND Parkinson's disease (PD) is a multi-system neurodegenerative disease affecting a subset of vulnerable cells in various brain structures, including brain stem nuclei. Selective degeneration of dopamine (DA) producing neurons in the pars compacta of the substantia nigra (SNc) is a key

Non-invasive Ventilation vs Oxygen Therapy After Extubation Failure

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Patients. Medical and surgical patients admitted to intensive care unit with 18 years of age or older in weaning from their first episode of mechanical ventilation for more than 24 hours were included. Patients with structural neurological disorder, acute toxic-metabolic neurological encephalopathy
Parkinson's disease (PD) is a neurodegenerative disease whose pathogenic mechanism is the degeneration of substantia nigra of the midbrain, causing the degeneration of dopaminergic neurons in the putamen and caudate nucleus of the striatum, and the dopamine content in the synapses decreases and

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Idiopathic Parkinson's disease (PD) is a progressive neurodegenerative disorder of unknown etiology, characterized by bradykinesia (slowness of movements) associated with tremor at rest and/or muscle rigidity. PD is typically associated with a significant loss of dopaminergic neurons in the
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge